Cardiac Protective Effects of Moringa oleifera Seeds in Spontaneous Hypertensive Rats

Joseph I Randriamboavonjy, Gervaise Loirand, Nathalie Vaillant1

  • 1INSERM, UMR S1087-CNRS UMR C6291, Nantes, France; Université de Nantes, Nantes, France;

Insights

Moringa oleifera seed powder improved cardiac function and reduced fibrosis in hypertensive rats, despite not lowering blood pressure. This suggests a potential benefit for heart conditions linked to high blood pressure.

Area of Science:

  • Cardiovascular research
  • Pharmacology
  • Integrative medicine

Background:

  • Hypertension leads to cardiac issues like left ventricular hypertrophy and fibrosis.
  • This study explores Moringa oleifera (MOI) seed powder's effects on the heart in hypertensive rats.

Purpose of the Study:

  • To investigate the cardiac effects of oral Moringa oleifera (MOI) seed powder in spontaneous hypertensive rats (SHR).

Main Methods:

  • Spontaneous hypertensive rats (SHR) were fed MOI seed powder (750mg/d for 8 weeks) or normal food.
  • Hemodynamic parameters were measured in vivo via telemetry; cardiac structure and function were assessed using echocardiography.
  • Histological studies evaluated fibrosis and protein expression.

Main Results:

  • MOI treatment did not alter blood pressure but reduced nocturnal heart rate and improved diastolic function in SHR.
  • Cardiac hypertrophy markers (left ventricular wall thickness, relative wall thickness) were reduced.
  • Significant reduction in left ventricular fibrosis was observed, linked to increased PPAR-α and δ expression and improved lipid/prostacyclin profiles.

Conclusions:

  • MOI demonstrates beneficial effects on cardiac structure and function in hypertensive rats, associated with PPAR-α and δ signaling.
  • These findings provide scientific support for the traditional Malagasy medicinal use of MOI for cardiac diseases related to hypertension.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.4K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.8K
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.5K